If you deal with recurrent UTIs, a new FDA-approved antibiotic called Blujepa could offer another treatment option—especially ...
Gepotidacin is an oral, first-in-class triazaacenaphthylene antibiotic that inhibits bacterial DNA replication by blocking 2 different type II topoisomerase enzymes.
The U.S. Food and Drug Administration (FDA) has approved GSK’s Blujepa (gepotidacin), a groundbreaking oral antibiotic for ...
A new antibiotic to treat stubborn urinary tract infection (UTI) and a blood-clot-dissolving intravenous treatment for acute ...
Pharmacy owner, three others held for illegal sale of intoxication drug (26-03-2025) ...
The Food and Drug Administration has approved a new antibiotic that can treat uncomplicated urinary tract infections, or ...
Everyday Health on MSN5d
New UTI Antibiotic Is the First Approved by the FDA in Nearly 30 YearsKey TakeawaysBlujepa (gepotidacin) is the first new antibiotic class approved in nearly 30 years, providing a crucial ...
The US Food and Drug Administration has approved a new type of antibiotic to treat urinary tract infections. The pill, ...
The Food and Drug Administration (FDA) has approved a new drug for treating urinary tract infections, the first such drug ...
The FDA has approved the drug for use in women and girls over the age of 12 who suffer from uncomplicated urinary tract ...
Blujepa is the first in a new class of oral antibiotics in 30 years. It is expected to launch in the second half of 2025 in the United States.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback